Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033

Jul 2024| TBR1580D| TBRC (Publisher)

Report Highlights

Including: 1) By Linker Type: Cleavable Linker; Non-Cleavable Linker
2) By Product: Kadcyla; Enhertu; Adcetris; Polivy; Trodelvy; Padcev
3) By Application: Hematopoietic Cancers; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor
4) By End User: Hospital; Clinics; Specialty Centers
Covering: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab

Antibody Drug Conjugates Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global antibody drug conjugates market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description:
Where is the largest and fastest-growing market for antibody drug conjugates? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The antibody drug conjugates market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider antibody drug conjugates market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by linker type, by product, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the antibody drug conjugates market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by linker type, by product, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for antibody drug conjugates providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2023-2033
Units considered $ Million
Segments covered By Linker Type, By Product, By Application, By End User
Industry covered Pharmaceuticals
Regions covered Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered China, Australia, India, Indonesia, Japan, South Korea, USA, Canada, Brazil, France, Germany, Italy, Spain, UK, Russia
Companies studied
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • Daiichi Sankyo Company Limited
  • Seagen Inc.
  • Genmab

Scope

Markets Covered:

  • By Linker Type: Cleavable Linker; Non-Cleavable Linker
  • By Product: Kadcyla; Enhertu; Adcetris; Polivy; Trodelvy; Padcev; Other Products
  • By Application: Hematopoietic Cancers; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Other Applications
  • By End User: Hospital; Clinics; Specialty Centers; Other End Users

Companies Mentioned: F. Hoffmann-La Roche Ltd.; Daiichi Sankyo Company Limited; Seagen Inc.; Gilead Sciences Inc.; Genmab

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; antibody drug conjugates indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
  • Table 2 : Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
  • Table 3 : Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 4 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 5 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 6 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 7 : Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 8 : Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 9 : Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
  • Table 10 : Asia-Pacific Population, By Country, 2018-2028, Millions
  • Table 11 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 12 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 13 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 14 : China GDP Per Capita, 2018-2023, $
  • Table 15 : China Population, 2018-2028, Millions
  • Table 16 : China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 17 : China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 18 : China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 19 : India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 20 : India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 21 : India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 22 : Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 23 : Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 24 : Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 25 : Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 26 : Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 27 : Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 28 : Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 29 : Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 30 : Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 31 : South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 32 : South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 33 : South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 34 : Western Europe GDP Per Capita, By Country, 2018-2023, $
  • Table 35 : Western Europe Population, By Country, 2018-2028, Millions
  • Table 36 : Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 37 : Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 38 : Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 39 : UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 40 : UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 41 : UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 42 : Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 43 : Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 44 : Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 45 : France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 46 : France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 47 : France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 48 : Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 49 : Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 50 : Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 51 : Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 52 : Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 53 : Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 54 : Eastern Europe GDP Per Capita, By Country, 2018-2023, $
  • Table 55 : Eastern Europe GDP Per Capita, By Country, 2018-2023, $
  • Table 56 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 57 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 58 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 59 : Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 60 : Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 61 : Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 62 : North America GDP Per Capita, By Country, 2018-2023, $
  • Table 63 : North America Population, By Country, 2018-2028, Millions
  • Table 64 : North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 65 : North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 66 : North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 67 : USA GDP Per Capita, 2018-2023, $
  • Table 68 : USA Population, 2018-2028, Millions
  • Table 69 : USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 70 : USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 71 : USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 72 : Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 73 : Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 74 : Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 75 : South America GDP Per Capita, By Country, 2017-2022, $
  • Table 76 : South America Population, By Country, 2017-2027, Millions
  • Table 77 : South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 78 : South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 79 : South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 80 : Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 81 : Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 82 : Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 83 : Middle East GDP Per Capita, By Country, 2018-2023, $
  • Table 84 : Middle East Population, By Country, 2018-2028, Millions
  • Table 85 : Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 86 : Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 87 : Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 88 : Africa GDP Per Capita, By Country, 2018-2023, $
  • Table 89 : Africa Population, By Country, 2018-2028, Millions
  • Table 90 : Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 91 : Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 92 : Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Table 93 : Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
  • Table 94 : F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
  • Table 95 : Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
  • Table 96 : Seagen Inc – Financial Overview, 2022, $Billion
  • Table 97 : Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
  • Table 98 : Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
  • Table 99 : Antibody Drug Conjugates Market, Competitive Benchmarking (In USD Millions)
  • Table 100 : Antibody Drug Conjugates Market, Competitive Dashboard
  • Table 101 : Global Antibody Drug Conjugates Market Size Gain ($ Million), 2023 – 2028, By Country
  • Table 102 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Linker Type, 2023 – 2028
  • Table 103 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Application, 2023 – 2028
  • Table 104 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By End User, 2023 – 2028
  • Table 105 : Global Antibody Drug Conjugates Market Size Gain ($ Million), Segmentation By Product, 2023 – 2028
  • Table 106 : Antibody Drug Conjugates Market Data Sources
  • Figure 1 : Global Antibody Drug Conjugates Market Segmentation By Linked Type
  • Figure 2 : Global Antibody Drug Conjugates Market Segmentation By Product
  • Figure 3 : Global Antibody Drug Conjugates Market Segmentation By Product
  • Figure 4 : Global Antibody Drug Conjugates Market Segmentation By End User
  • Figure 5 : Global Antibody Drug Conjugates Market, Historic, 2018 – 2023, $ Million
  • Figure 6 : Global Antibody Drug Conjugates Market, Forecast, 2023 – 2028, 2033F, $ Million
  • Figure 7 : Global Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 8 : Global Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 9 : Global Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 10 : Global Antibody Drug Conjugates Market, Segmentation By Product, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 11 : Global Antibody Drug Conjugates Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 12 : Global Antibody Drug Conjugates Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 13 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 14 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 15 : Asia-Pacific Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 16 : China Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 17 : China Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 18 : China Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 19 : India Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 20 : India Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 21 : India Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 22 : Japan Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 23 : Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 24 : Japan Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 25 : Australia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 26 : Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 27 : Australia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 28 : Indonesia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 29 : Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 30 : Indonesia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 31 : South Korea Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 32 : South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 33 : South Korea Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 34 : Western Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 35 : Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 36 : Western Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 37 : UK Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 38 : UK Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 39 : UK Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 40 : Germany Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 41 : Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 42 : Germany Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 43 : France Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 44 : France Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 45 : France Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 46 : Italy Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 47 : Italy Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 48 : Italy Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 49 : Spain Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 50 : Spain Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 51 : Spain Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 52 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 53 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 54 : Eastern Europe Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 55 : Russia Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 56 : Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 57 : Russia Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 58 : North America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 59 : North America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 60 : North America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 61 : USA Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 62 : USA Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 63 : USA Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 64 : Canada Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 65 : Canada Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 66 : Canada Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 67 : South America Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 68 : South America Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 69 : South America Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 70 : Brazil Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 71 : Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 72 : Brazil Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 73 : Middle East Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 74 : Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 75 : Middle East Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 76 : Africa Antibody Drug Conjugates Market, Segmentation By Linker Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 77 : Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 78 : Africa Antibody Drug Conjugates Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
  • Figure 79 : Global Antibody Drug Conjugates Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
  • Figure 80 : F. Hoffmann-La Roche Ltd – Financial Overview, 2018 – 2022, $ Billion
  • Figure 81 : Daiichi Sankyo Company Limited – Financial Overview, 2018 – 2022, $ Billion
  • Figure 82 : Gilead Sciences Inc – Financial Overview, 2018 – 2022, $ Billion
  • Figure 83 : Genmab A/S – Financial Overview, 2018 – 2022, $ Billion
  • Figure 84 : Geographic Regions Covered

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Antibody Drug Conjugates Global Market Report 2023

  • Date - Feb 2023
  • Code - TBR1580C

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor
3) By Product: Adcertis; Kadcyla
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology
5) By End User: Hospital; Clinics
Covering: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; ImmunomedicsInc.; Oxford BioTherapeutics

Antibody Drug Conjugates Global Market Report ...

Antibody Drug Conjugates Global Market Report 2022

  • Date - Mar 2022
  • Code - TBR1580B

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others
3) By Product: Adcertis; Kadcyla; Others
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others
5) By End User: Hospital; Clinics; Others
Covering: Bayer AG; Concortis Biotherapeutics; F.Hoffman-La Roche Ltd.; Immunomedics ...

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

  • Date - Sep 2021
  • Code - TBR1580A

Including: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others
2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others
3) By Product: Adcertis; Kadcyla; Others
4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others
5) By End User: Hospital; Clinics; Others
Covering: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche ...

The Business Research Company
Price: $5000

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS